Clearmind Medicine Inc Share Price Today: Live Updates & Key Insights

Clearmind Medicine Inc share price today is $1.62, up -3.01%. The stock opened at $1.66 against the previous close of $1.66, with an intraday high of $1.67 and low of $1.61.

Clearmind Medicine Inc Share Price Chart

Clearmind Medicine Inc

us-stock
To Invest in {{usstockname}}
us-stock

Clearmind Medicine Inc Share Price Performance

$1.62 -0.0301(-3.01%) CMND at 27 Jul 2026 02:28 PM Biotechnology
Lowest Today 1.61
Highest Today 1.67
Today’s Open 1.66
Prev. Close 1.66
52 Week High 524.00
52 Week Low 1.61
Day’s Range: Low 1.61 High 1.67
52-Week Range: Low 1.61 High 524.00
1 day return -
1 Week return -10.69
1 month return -29.23
3 month return +125.64
6 month return -34.25
1 year return +63.72
3 year return -87.08
5 year return -
10 year return -

Clearmind Medicine Inc Institutional Holdings

XTX Topco Ltd 0.21

HRT FINANCIAL LLC 0.16

AdvisorShares Psychedelics ETF 0.08

AdvisorShares Investments, LLC 0.07

Royal Bank of Canada 0.00

Advisor Group Holdings, Inc. 0.00

JPMorgan Chase & Co 0.00

Morgan Stanley - Brokerage Accounts 0.00

NATIONAL BANK OF CANADA /FI/ 0.00

Susquehanna International Group, LLP 0.00

UBS Group AG 0.00

Clearmind Medicine Inc Market Status

Clearmind Medicine Inc Fundamentals

Market Cap 2.47 M

PB Ratio 0.2153

PE Ratio 0.0

Enterprise Value -11.03 M

Total Assets 6.08 M

Volume 33531

Clearmind Medicine Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-69193 -0.1M, FY24:-26703 -0.0M, FY23:-77566 -0.1M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-5405754 -5.4M, FY24:-5254678 -5.3M, FY23:-11627302 -11.6M, FY22:-9410806 -9.4M, FY21:-4122652 -4.1M

Quarterly Revenue Q2/2026:0 0.0M, Q1/2026:0 0.0M, Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M

Quarterly Profit Q2/2026:-13901 -0.0M, Q1/2026:-13318 -0.0M, Q4/2025:-17993 -0.0M, Q3/2025:-17254 -0.0M, Q2/2025:-16537 -0.0M

Quarterly Net worth Q2/2026:-2047653 -2.0M, Q1/2026:-3852238 -3.9M, Q4/2025:-964044 -1.0M, Q3/2025:-1809906 -1.8M, Q2/2025:-1083074 -1.1M

About Clearmind Medicine Inc & investment objective

Company Information Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Clearmind Medicine Inc FAQs

What is the share price of Clearmind Medicine Inc today?

The current share price of Clearmind Medicine Inc is $1.62.

Can I buy Clearmind Medicine Inc shares in India?

Yes, Indian investors can buy Clearmind Medicine Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Clearmind Medicine Inc shares in India?

You can easily invest in Clearmind Medicine Inc shares from India by:

Can I buy fractional shares of Clearmind Medicine Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Clearmind Medicine Inc?

Clearmind Medicine Inc has a market cap of $2.47 M.

In which sector does Clearmind Medicine Inc belong?

Clearmind Medicine Inc operates in the Biotechnology sector.

What documents are required to invest in Clearmind Medicine Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Clearmind Medicine Inc?

The PE ratio of Clearmind Medicine Inc is N/A and the PB ratio is 0.22.